Bruin Biometrics, LLC (“BBI”), a medical device company with two biometric sensing products ready for market in Europe and the United States, announced it has closed a $10 million round of funding which was oversubscribed by almost $2.7 million. The funds will be deployed to market the developed products, complete clinical trials and continue R&D on the product pipeline.
“Investors are responding to this important opportunity ideally timed to solve critical issues that cost healthcare systems globally billions in expensive, preventable diagnostics and treatments. BBI’s biometric scanning technology is proven and ready to improve patient care simply and inexpensively,” said BBI’s Chief Executive Officer Martin Burns. “Investors, physicians and hospitals understand these sensors detect a number of key health conditions. They soon will become another tool that nurses and other healthcare workers use when checking a patient’s vitals, just like the blood pressure cuff is today.”
BBI previously completed two initial rounds of funding for $4 million.
For more information, visit www.bruinbiometrics.com.
